FeesSafety
Pluang+

Waters Corp Q3 revenue beats estimates; raises 2026 guidance and acquires MOBILion Systems

Company Fundamentals
03 Nov 2026, 13:00 WIB
PRNewsWire
View Source
Bullish
Waters Corp Q3 revenue beats estimates; raises 2026 guidance and acquires MOBILion Systems

Waters Corporation reported Q3 2026 revenue of $1.767 billion, exceeding guidance with 9% organic growth. Adjusted EPS rose 21% to $4.10, driven by strong performance in Analytical Sciences and Biosciences divisions. The company raised its full-year 2026 revenue and EPS guidance, citing robust demand and successful integration of acquisitions. Waters also acquired MOBILion Systems to expand its mass spectrometry and proteomics capabilities, with a growth framework for 2027 to be outlined soon.

Waters Corporation's Q3 2026 financial results provide context for the health sector's performance. For readers following health stocks, here is Pluang's market snapshot as of Nov 03, 2026 17:51 WIB: out of 150 priced US health-sector stocks, 70 rose and 69 fell. Among notable movers, NUVB gained 4.79% to USD 4.81 with a typical hold time of 18 days, contrasting with INO which dropped 4.76% to USD 1.80 and had a nearly balanced Pluang order activity of 51% Sell to 49% Buy over 42 days, while RVTY declined 4.38% to USD 145.01 with a typical hold time of 13 days.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
1 hour ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
1 hour ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
1 hour ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
2 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App